RP Mason, P Libby, DL Bhatt - Arteriosclerosis, thrombosis, and …, 2020 - Am Heart Assoc
Patients with well-controlled LDL (low-density lipoprotein) levels still have residual cardiovascular risk associated with elevated triglycerides. Epidemiological studies have …
AS Abdelhamid, N Martin, C Bridges… - … of systematic reviews, 2018 - ncbi.nlm.nih.gov
Background Evidence on the health effects of total polyunsaturated fatty acids (PUFA) is equivocal. Fish oils are rich in omega‐3 PUFA and plant oils in omega‐6 PUFA. Evidence …
N Kaur, V Chugh, AK Gupta - Journal of food science and technology, 2014 - Springer
During the recent decades, awareness towards the role of essential fatty acids in human health and disease prevention has been unremittingly increasing among people. Fish, fish …
Segundo a Organização Mundial de Saúde (OMS), a Doença Cardiovascular (DCV) é a principal causa de morte no mundo, perfazendo 30% das mortes globais1, taxa …
SM Kwak, SK Myung, YJ Lee, HG Seo… - Archives of internal …, 2012 - jamanetwork.com
Background Although previous randomized, double-blind, placebo-controlled trials reported the efficacy of omega-3 fatty acid supplements in the secondary prevention of cardiovascular …
WS Harris, D Mozaffarian, M Lefevre, CD Toner… - The Journal of …, 2009 - Elsevier
There is considerable interest in the impact of (n-3) long-chain PUFA in mitigating the morbidity and mortality caused by chronic diseases. In 2002, the Institute of Medicine …
BM Yashodhara, S Umakanth… - Postgraduate …, 2009 - academic.oup.com
Abstract Omega-3 fatty acids (ω-3 FAs) are essential fatty acids with diverse biological effects in human health and disease. Reduced cardiovascular morbidity and mortality is a …
TJ Lyons, A Basu - Translational Research, 2012 - Elsevier
Biomarkers are conventionally defined as “biological molecules that represent health and disease states.” They typically are measured in readily available body fluids (blood or urine) …
KM Borow, JR Nelson, RP Mason - Atherosclerosis, 2015 - Elsevier
Residual cardiovascular (CV) risk remains in dyslipidemic patients despite intensive statin therapy, underscoring the need for additional intervention. Eicosapentaenoic acid (EPA), an …